These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23137282)

  • 21. Switched alternative splicing of oncogene CoAA during embryonal carcinoma stem cell differentiation.
    Yang Z; Sui Y; Xiong S; Liour SS; Phillips AC; Ko L
    Nucleic Acids Res; 2007; 35(6):1919-32. PubMed ID: 17337438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TCF3 inhibits F9 embryonal carcinoma growth by the down-regulation of Oct4.
    Lin G; Zhao L; Yin F; Lan R; Li L; Zhang X; Zhang H; Yang B
    Oncol Rep; 2011 Oct; 26(4):893-9. PubMed ID: 21725619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
    Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
    Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
    Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells.
    Bahrami AR; Matin MM; Andrews PW
    Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of DPPA4 and DPPA2 as a novel family of pluripotency-related oncogenes.
    Tung PY; Varlakhanova NV; Knoepfler PS
    Stem Cells; 2013 Nov; 31(11):2330-42. PubMed ID: 23963736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
    Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
    Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation.
    Salomonis N; Schlieve CR; Pereira L; Wahlquist C; Colas A; Zambon AC; Vranizan K; Spindler MJ; Pico AR; Cline MS; Clark TA; Williams A; Blume JE; Samal E; Mercola M; Merrill BJ; Conklin BR
    Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10514-9. PubMed ID: 20498046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex-determining region Y-box 2 and GA-binding proteins regulate the transcription of liver receptor homolog-1 in early embryonic cells.
    Kanno M; Yazawa T; Kawabe S; Imamichi Y; Usami Y; Ju Y; Matsumura T; Mizutani T; Fujieda S; Miyamoto K
    Biochim Biophys Acta; 2014 May; 1839(5):406-14. PubMed ID: 24705138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AW551984: a novel regulator of cardiomyogenesis in pluripotent embryonic cells.
    Yasuda S; Hasegawa T; Hosono T; Satoh M; Watanabe K; Ono K; Shimizu S; Hayakawa T; Yamaguchi T; Suzuki K; Sato Y
    Biochem J; 2011 Jul; 437(2):345-55. PubMed ID: 21554246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-neuronal release of gamma-aminobutyric Acid by embryonic pluripotent stem cells.
    Teng L; Tang YB; Sun F; An SM; Zhang C; Yang XJ; Lv HY; Lu Q; Cui YY; Hu JJ; Zhu L; Chen HZ
    Stem Cells Dev; 2013 Nov; 22(22):2944-53. PubMed ID: 23799822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells.
    Matin MM; Walsh JR; Gokhale PJ; Draper JS; Bahrami AR; Morton I; Moore HD; Andrews PW
    Stem Cells; 2004; 22(5):659-68. PubMed ID: 15342930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MBNL proteins repress ES-cell-specific alternative splicing and reprogramming.
    Han H; Irimia M; Ross PJ; Sung HK; Alipanahi B; David L; Golipour A; Gabut M; Michael IP; Nachman EN; Wang E; Trcka D; Thompson T; O'Hanlon D; Slobodeniuc V; Barbosa-Morais NL; Burge CB; Moffat J; Frey BJ; Nagy A; Ellis J; Wrana JL; Blencowe BJ
    Nature; 2013 Jun; 498(7453):241-5. PubMed ID: 23739326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming.
    Gabut M; Samavarchi-Tehrani P; Wang X; Slobodeniuc V; O'Hanlon D; Sung HK; Alvarez M; Talukder S; Pan Q; Mazzoni EO; Nedelec S; Wichterle H; Woltjen K; Hughes TR; Zandstra PW; Nagy A; Wrana JL; Blencowe BJ
    Cell; 2011 Sep; 147(1):132-46. PubMed ID: 21924763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal.
    Greber B; Lehrach H; Adjaye J
    BMC Dev Biol; 2007 May; 7():46. PubMed ID: 17506876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
    Poursani EM; Mehravar M; Soltani BM; Mowla SJ
    Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation of the Oct4A enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells.
    Baryshev M; Inashkina I; Salmina K; Huna A; Jackson TR; Erenpreisa J
    Cell Cycle; 2018; 17(3):362-366. PubMed ID: 29372665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines.
    Vencken SF; Sethupathy P; Blackshields G; Spillane C; Elbaruni S; Sheils O; Gallagher MF; O'Leary JJ
    BMC Genomics; 2014 Aug; 15():711. PubMed ID: 25156079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of variable levels of RARĪ± and RARĪ³ proteins in pluripotent and differentiating mouse embryonal carcinoma and mouse embryonic stem cells.
    Buchanan FQ; Rochette-Egly C; Asson-Batres MA
    Cell Tissue Res; 2011 Oct; 346(1):43-51. PubMed ID: 21987218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental regulation of neurogenesis in the pluripotent human embryonal carcinoma cell line NTERA-2.
    Przyborski SA; Morton IE; Wood A; Andrews PW
    Eur J Neurosci; 2000 Oct; 12(10):3521-8. PubMed ID: 11029621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.